T003

Triple HIV Antibody Trial

Are you…

18 – 65 years of age?
Living with HIV?
Taking antiretroviral treatment (ART)?

Could an infusion of an investigational antibody product be a prevention/treatment of HIV?

This study is assessing the use of an infusion of three antibodies as an alternative treatment for people living with HIV. We want to see if these antibodies can control the virus during an interruption of your ART. Your participation would be for one year, and you would be compensated up to $1925 for expenses and travel associated with participation. Learn more

You may be compensated up to $1925 for expenses and travel associated with participation.
If you would like to be considered for participation, please complete the form at right.
We are available to discuss your concerns and answer your questions. You can call us at (617) 735-4610 or email us at cvvrtrials@bidmc.harvard.edu.

Name*
First Last
Email*
Phone*
Consent
I would like to receive information on other Center for Virology and Vaccine Research studies.
Which study are you interested in?*
How did you hear about this study?*
If you learned about our study through other means, please specify here.
Preferred method of contact*
- Phone
- Email
- Either
CAPTCHA

T003

Center for Virology and Vaccine Research

CVVR Clinical Trials Unit

Affiliates